VTYX Stockholders with Large Losses Should Contact Robbins LLP to Learn More about the Ventyx Biosciences, Inc. Class Action
26 mars 2024 00h27 HE
|
Robbins LLP
Ventyx Biosciences, Inc. (VTYX) Allegedly Misled Investors Regarding the Viability and Efficacy of its Psoriasis Drug